Risk control of host cell proteins in one therapeutic antibody produced by concentrated fed‐batch (CFB) mode
Abstract Multiple control strategies, including a downstream purification process with well‐controlled parameters and a comprehensive release or characterization for intermediates or drug substances, were implemented to mitigate the potential risk of host cell proteins (HCPs) in one concentrated fed...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley-VCH
2023-03-01
|
Series: | Engineering in Life Sciences |
Subjects: | |
Online Access: | https://doi.org/10.1002/elsc.202200060 |